Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-08

Clinical Trial Update: Can MRI Evaluate Beta-blocker Response in Portal Hypertension?

View source ↗

Summary

A clinical trial update from University of Nottingham explores using MRI to assess beta-blocker response in patients with liver cirrhosis and portal hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beta blocker (unspecified) (beta blocker)

Snippet

Sponsor: University of Nottingham | Conditions: Liver Cirrhosis, Portal Hypertension | Status: UNKNOWN